No answer available

No answer available

No answer available

A »The United Kingdom hosts several established manufacturers and distributors of high-purity industrial ethanol that serve the pharmaceutical sector, a market segment that demands rigorous compliance with pharmacopoeial standards such as the British Pharmacopoeia (BP) and the United States Pharmacopeia (USP), as well as Good Manufacturing Practice (GMP) certifications. One of the leading domestic producers is Ineos, which operates a major ethanol plant in Grangemouth, Scotland, and supplies a range of high-purity grades—including 96% and 99.9% anhydrous ethanol—that are widely used in pharmaceutical manufacturing for extraction, synthesis, and as a solvent in active pharmaceutical ingredients (APIs). Ineos ethanol is derived from both synthetic and bio-based feedstocks, and the company holds ISO 9001 and often GMP status for its dedicated pharma-grade product lines. Another key supplier is Greenfield Global, which maintains a significant production facility in Portbury, England, offering high-purity ethanol streams specifically certified for pharmaceutical and healthcare applications. Their portfolio includes USP/BP-grade ethanol (both 95% and absolute) produced via fermentation of corn or wheat, with rigorous quality control and batch traceability to meet MHRA and FDA guidelines. Similarly, BP and Shell Chemicals are active in the UK market, supplying synthetic ethanol—typically derived from ethylene—that meets high purity thresholds (e.g., >99.8%) and is often accompanied by certificates of analysis attesting to low levels of impurities such as aldehydes and methanol. For smaller-scale or specialized pharmaceutical needs, national distributors like VWR International and Fisher Scientific—though not manufacturers—source ethanol from these primary producers and offer validated, purity-guaranteed products with full documentation. Additionally, Thomas Swan & Co., a UK-based fine chemical manufacturer, provides custom grades of high-purity ethanol for research and pilot-scale pharma use, emphasizing its ability to meet the strict residual solvent limits outlined in ICH Q3C. Companies such as ABRENTA, formerly known as Brenntag UK & Ireland, also distribute pharmaceutical-grade ethanol from multiple manufacturing partners, offering technical support and blending services to achieve specific concentrations. It is important to note that UK pharmaceutical firms typically require ethanol that is either denatured with approved agents (such as BP denatured ethanol) for industrial use or non-denatured for certain extraction processes, and suppliers must comply with the UK Alcohol Duty regulations. Overall, the landscape is dominated by large integrated chemical producers backed by robust quality systems, while smaller specialist firms fill niche requirements. The choice of supplier often depends on volume, purity specification (e.g., absolute vs. 96% v/v), denaturing profile, and the need for full regulatory support including audit readiness.

No answer available

No answer available

No answer available